A detailed history of Central Trust CO transactions in Embecta Corp. stock. As of the latest transaction made, Central Trust CO holds 27 shares of EMBC stock, worth $382. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27
Previous 42 35.71%
Holding current value
$382
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$10.13 - $14.6 $151 - $219
-15 Reduced 35.71%
27 $0
Q4 2023

Jan 24, 2024

SELL
$12.87 - $19.09 $25 - $38
-2 Reduced 4.55%
42 $0
Q3 2023

Oct 26, 2023

SELL
$15.0 - $22.17 $105 - $155
-7 Reduced 13.73%
44 $0
Q1 2023

Apr 19, 2023

SELL
$23.07 - $32.77 $1,199 - $1,704
-52 Reduced 50.49%
51 $1,000
Q4 2022

Jan 26, 2023

SELL
$25.29 - $35.48 $3,692 - $5,180
-146 Reduced 58.63%
103 $0
Q3 2022

Nov 17, 2022

SELL
$24.0 - $33.42 $3,912 - $5,447
-163 Reduced 39.56%
249 $7,000
Q2 2022

Aug 09, 2022

BUY
$24.78 - $33.36 $10,209 - $13,744
412 New
412 $10,000

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $820M
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Central Trust CO Portfolio

Follow Central Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Central Trust CO with notifications on news.